Denali Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
DNLI Key Statistics
Stock Snapshot
With a market cap of 2.64B, Denali Therapeutics(DNLI) trades at $17.92. The stock has a price-to-earnings ratio of -6.18.
During the trading session on 2025-11-22, Denali Therapeutics(DNLI) shares reached a daily high of $18.23 and a low of $16.87. At a current price of $17.92, the stock is +6.2% higher than the low and still -1.7% under the high.
Trading activity shows a volume of 1.45M, compared to an average daily volume of 1.51M.
Over the past 52 weeks, Denali Therapeutics(DNLI) stock has traded between a high of $26.18 and a low of $10.57.
Over the past 52 weeks, Denali Therapeutics(DNLI) stock has traded between a high of $26.18 and a low of $10.57.
DNLI News
Denali Therapeutics recently announced significant leadership changes, with Chief Medical Officer Carole Ho departing for Eli Lilly, Peter Chin appointed as Act...
